25 April 2013 10:39 [Source: ICIS news]
LONDON (ICIS)--After several false starts dating back to 2008, German chemicals giant Evonik went public on Thursday, with shares up in early day trading.
Some 14.5% of the company has been placed in free float in the form of 466 million shares, with 12.2% of that total sold in private placements in February and March this year.
Evonik said on Thursday that the company had sold an additional 2.3% stake to domestic and institutional investors on 24 April, ahead of the listing, for a price of €32.20 ($41.82) per share. Shares were trading at €32.89 apiece in Frankfurt as of 09:37 GMT, from early-day highs of €33.20. The company described the number of investors as in the "low three-digit[s]".
Following the listing, the RAG Foundation – which previously held 74.99% of the company – has reduced its stake to 68.9%, while former 25.01% stakeholder – private equity firm CVC Capital Partners – has reduced its stake to 18.9%.
Singapore-based sovereign wealth fund Temasek now holds 4.6% of the company through a wholly-owned subsidiary, according to Evonik’s initial public offering (IPO) prospectus.
The RAG Foundation had originally planned to list the company in 2008, but scrapped plans as a result of the global economic crisis, opting instead to sell a 25.01% stake to CVC.
Another attempted listing was cancelled in 2012 due to the weak European economy.
($1 = €0.77)
|ICIS news FREE TRIAL|
|Get access to breaking chemical news as it happens.|
|ICIS Global Petrochemical Index (IPEX)|
Asian Chemical Connections